NanoEcho
0.299 SEK -3.71%Be the first to follow this company
NanoEcho is active in healthcare, with a main focus in rectal cancer diagnostics. The company is active in the clinical stage, where a new diagnostic method is being developed to determine whether early rectal cancer has spread to nearby lymph nodes. The method aims to provide a correct diagnosis and individualized treatment. NanoEcho was founded in 2013 and has its headquarters in Lund.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
NANECH
Daily low / high price
0.281 / 0.326
SEK
Market cap
51.88M SEK
Turnover
165.34K SEK
Volume
555K
Financial calendar
Interim report
2024-10-24
Annual report
2025-02-13
Interim report
2025-04-30
Interim report
2025-08-21
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 16.6 % | 16.6 % |
Maxistans AB | 10.3 % | 10.3 % |
Cloudo | 8.1 % | 8.1 % |
Gunther Wikberg Holding | 7.2 % | 7.2 % |
Givetvis AB | 6.0 % | 6.0 % |
Quiq Holding AB | 3.5 % | 3.5 % |
Öresund Holding AB | 2.5 % | 2.5 % |
Nordnet Pensionsförsäkring AB | 2.4 % | 2.4 % |
ATH Invest | 2.4 % | 2.4 % |
Ghannad, Omid | 1.7 % | 1.7 % |
ShowingAll content types
NanoEcho erhåller godkännande från Läkemedelsverket för användning av den järnoxidbaserade nanopartikeln i planerad klinisk studie
NanoEcho och Lunds universitet publicerar vetenskaplig artikel om fantomer för magnetomotoriskt ultraljud
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools